TIA1 antibody: RN014P


Antibody Info
Product_IDRN014P
Lot_ID1
Host_organismrabbit
SourceMBLI
Antibody_DCC_IDENCAB000BGC
Target Info
GeneNameTIA1
Phosphate
Target_nameTIA1-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 HepG2_MBLI_RN014P_001_TIA1.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using TIA1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-TIA1 antibody (lanes under 'TIA1').

Caption: IP-Western Blot analysis of HepG2 whole cell lysate using TIA1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-TIA1 antibody (lanes under 'TIA1').

Method: immunoprecipitation

Releated Sample: eCLIP:215

Status: Released

Lab: Yeo Lab

TIA1_Secondary_Western.jpg<br>Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.

Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.

Releated Sample: BGKLV11-59

Status: Released

Lab: Graveley Lab

K562 MBLI_RN014P_001_TIA1.png<br>Caption: IP-Western blot analysis of K562 whole cell lysate using TIA1 specific antibody. Lane 1 is 2.5% of 0.5mg input lysate, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal Anti-TIA1pAb. The last three lanes are the same pattern, but with IgG control instead of TIA1 antibody.

Caption: IP-Western blot analysis of K562 whole cell lysate using TIA1 specific antibody. Lane 1 is 2.5% of 0.5mg input lysate, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal Anti-TIA1pAb. The last three lanes are the same pattern, but with IgG control instead of TIA1 antibody.

Method: immunoprecipitation

Releated Sample: eCLIP:285

Status: Released

Lab: Yeo Lab

TIA1_Secondary_Western.jpg<br>Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.

Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.

Releated Sample: BGKLV11-59

Status: Released

Lab: Graveley Lab